A new four-year, $3.26 million grant from the National Institute of Neurological Disorders and Stroke (NINDS), a part of the National Institutes of Health (NIH), establishes the first Undiagnosed Diseases Network (UDN) site in the New York metropolitan area.
Mount Sinai Health SystemSep 17 2024 A new four-year, $3.26 million grant from the National Institute of Neurological Disorders and Stroke , a part of the National Institutes of Health , establishes the first Undiagnosed Diseases Network site in the New York metropolitan area.
"There are approximately 25 million Americans who suffer from a rare disorder," said Dr. Gelb, who is also Dean for Child Health Research and Director of the Center for Molecular Cardiology at Icahn Mount Sinai. "We hope this program will end diagnostic odysseys and inform meaningful therapies for these traits. We also hope this work will increase awareness among physicians in the Mount Sinai Health System about the utility of genomic medicine.
When patients and families endure symptoms without a diagnosis, it can cause a great deal of emotional stress. The search for answers can be both a financial burden and a physical burden as patients jump from provider to provider, hoping for a solution. With our new Center, we aim to shed light on diseases that are not well recognized due to low incidence, document new diseases that will hopefully lead to cures, and uncover rare variations of more common diseases.
Child Health Diagnostic Genetics Genomic Genomics Health Care Hospital Medicine Pediatrics Research
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
New Brighton's New Palace and Adventureland Tops Seaside Heritage Network ListNew Brighton's iconic entertainment centre, New Palace and Adventureland, has been voted the top seaside destination in this year's Bucket and Spade List by the Seaside Heritage Network. The public vote highlighted the value of continuity and nostalgia in seaside experiences.
Read more »
New AI technology uses voice analysis to detect undiagnosed type 2 diabetesNew research to be presented at this year's Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept), highlights the potential of using voice analysis to detect undiagnosed type 2 diabetes (T2D) cases.
Read more »
A potential pathway may guide new therapies for inflammatory bowel disease and other inflammatory diseasesThere is a critical unmet need to help tighten and maintain a healthy intestinal barrier and treat a leaky gut. Researchers have now found that a unique strain of probiotic bacteria, Bifidobacterium bifidum BB1, enhances intestinal barrier function and protects against penetration of bacteria and various harmful agents in the intestine.
Read more »
Cancer drug holds promise as a new treatment for neurodegenerative diseasesA type of drug developed for treating cancer holds promise as a new treatment for neurodegenerative diseases such as Alzheimer's, according to a recent study by researchers at Penn State, Stanford University and an international team of collaborators.
Read more »
Study reveals a new target for universal treatment for autoimmune diseasesMore than two decades ago, a research team in the lab of David Hafler, a Yale researcher who at the time was at Harvard, discovered a type of T cell in humans that suppresses the immune system; they later found that these so-called regulatory T cells, when defective, are an underlying cause of autoimmune disease, specifically multiple sclerosis...
Read more »
New ESC guidelines integrate management of aortic and peripheral arterial diseasesThe 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases (PAAD) evaluate these vascular diseases together as part of same cardiovascular system, appreciating that patients with aortic diseases are at risk of having peripheral vascular diseases and vice versa.
Read more »